Workflow
12-lipoxygenase inhibition
icon
Search documents
Cadrenal Therapeutics (NasdaqCM:CVKD) Conference Transcript
2026-03-12 20:02
Cadrenal Therapeutics (NasdaqCM:CVKD) Conference March 12, 2026 03:00 PM ET Company ParticipantsQuang Pham - Chairman and CEONone - Company RepresentativeConference Call ParticipantsDavid Bautz - Senior Equity AnalystNoneHello, and welcome to the Life Science Investor Forum. On behalf of OTC Markets and our co-host, Zacks Small Cap Research, we are very pleased you have joined us. The next presentation of the day is from Cadrenal Therapeutics. Their session will be moderated by David Bautz, Senior Equity An ...